L M Strawn

Statistics

Publications

Citations

515

H-Index

Active since

1996

Affiliations

Maxygen (United States)(Current)

L M Strawn is an author at Maxygen (United States) specializing in vascular endothelial growth factor receptor signaling, molecular oncology, and tyrosine kinase inhibition.

Publications per year

1996–2000

Publications

Flk-1 as a target for tumor growth inhibition.

L M Strawn, Gerald McMahon, Harald App et al. · PubMed · 1996 · 318 citations

Medicine, Oncology, Pharmacology +15

The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and function.

Dirk B. Mendel, Randall Schreck, David C. West et al. · PubMed · 2000 · 197 citations

Medicine, Oncology, Pharmacology +15

1–2 of 2